All BRCA1/2 carriers without previous history of breast or ovarian cancer are encouraged to participate in a specific preventive program and recommended to consider risk-reducing surgeries at the oncological institutions in the Czech Republic. The gene discussed is BRCA1; the disease is ovarian carcinoma.